Guangzhi Cong

Dr. Guangzhi Cong

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GCGuangzhi Cong
Guangzhi Cong
XCXiangdong Cui
Xiangdong Cui
RFRicardo Jose Ferrari
Ricardo Jose Ferrari
IPIraklis Pipinos
Iraklis Pipinos
GCGeorge Casale
George Casale
USUlka Sachdev
Ulka Sachdev
Most patients with critical limb ischemia (CLI) from peripheral arterial disease (PAD) do not have antecedent intermittent claudication (IC). We hypothesized that transcriptomic analysis would identify CLI-specific pathways, particularly in regards to fibrosis. Derivation cohort data from muscle biopsies in PAD and non-PAD (controls) was obtained from the Gene Expression Omnibus (GSE120642). Transcriptomic analysis indicated CLI patients (N = 16) had a unique gene expression profile, when compared with non-PAD controls (N = 15) and IC (N = 20). Ninety-eight genes differed between controls and IC, 2489 genes differed between CLI and controls, and 2783 genes differed between CLI and IC patients. Pathway enrichment analysis showed that pathways associated with TGFβ, collagen deposition, and VEGF signaling were enriched in CLI but not IC. Receiver operating curve (ROC) analysis of nine fibrosis core gene expression revealed the areas under the ROC (AUC) were all >0.75 for CLI. Furthermore, the fibrosis area (AUC = 0.81) and % fibrosis (AUC = 0.87) in validation cohort validated the fibrosis discrimination CLI from IC and control (all n = 12). In conclusion, transcriptomic analysis identified fibrosis pathways, including those involving TGFβ, as a novel gene expression feature for CLI but not IC. Fibrosis is an important characteristic of CLI, which we confirmed histologically, and may be a target for novel therapies in PAD.

19 December 2024 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
CYCongyan Ye
Congyan Ye
XMXueping Ma
Xueping Ma
BSBo Shi
Bo Shi
RYRui Yan
Rui Yan
SFShizhe Fu
Shizhe Fu
GCGuangzhi Cong
Guangzhi Cong
Background: Acute kidney injury (AKI) complicates transcatheter aortic valve replacement (TAVR), leading to higher mortality. The incidence and effects of AKI on clinical outcomes in patients undergoing TAVR without chronic kidney disease (CKD) are unclear. We aimed to determine the association between AKI and in-hospital outcomes in patients with TAVR using propensity score matching (PSM). Methods: Using International Classification of Diseases-10th Revision codes, we queried the National Inpatient Sample for TAVR performed between 2016 and 2021. Patients were divided into two groups according to perioperative AKI development. Patients with CKD or on permanent hemodialysis at baseline were excluded. We conducted 1:1 PSM to assemble a cohort of patients with similar baseline characteristics. Multivariate logistic regression was used to assess the association between AKI and in-hospital outcomes. Sensitivity analysis was conducted to evaluate the robustness of our inferences. Results: Of 47,372 unweighted patient admissions for TAVR, 1617 (3.41%) had a concomitant diagnosis of AKI. The incidence of AKI decreased from 4.82 to 3.18% from 2016 to 2021 (P-trend < 0.01). Before PSM, patients with AKI had a significantly higher rate of in-hospital mortality compared with those without AKI (6.12% vs. 0.48%, respectively; odds ratio [OR] 8.59, 95% confidence interval [CI] 6.32–11.68). Using the PSM algorithm, 1579 well-matched patients were included in each group. After PSM, an association was observed between patients with TAVR and concomitant AKI and a higher risk of in-hospital mortality (6.21% vs. 1.08%, respectively; OR 5.96; 95% CI 3.54–10.04). In subgroup analyses stratified according to age (≤ 80 and > 80 years), sex (male/female), and hypertension status, consistent associations were observed between AKI and the risk of in-hospital mortality. AKI patients were at higher risk for acute myocardial infarction (OR 1.78, 95% CI 1.35–2.34), major bleeding (OR 1.62, 95% CI 1.13–2.33), blood transfusion (OR 1.65, 95% CI 1.28–2.11), and cardiogenic shock (OR 3.73, 95% CI 2.77–5.01). No significant betweengroup differences were observed in stroke (P = 0.12). Conclusion: AKI was a strong predictor of in-hospital mortality in patients undergoing TAVR without CKD and was associated with higher post-procedure complication rates.

6 February 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XZXuehu Zhang
Xuehu Zhang
AGAoqin Gu
Aoqin Gu
LZLirong Zhou
Lirong Zhou
YMYuru Ma
Yuru Ma
PWPeng Wu
Peng Wu
SJShaobin Jia
Shaobin Jia
Background: Myocardial ischemia-reperfusion injury (I/R) significantly exacerbates cardiomyocyte damage post-recanalization therapy in acute myocardial infarction. Pyroptosis and the NLRP3 inflammasome are crucial in I/R, yet the precise mechanism remains unclear. Materials and Methods: Transcriptomics, proteomics, and single-cell transcriptomics were employed to examine cellular subtype changes and pyroptosis-associated gene regulation in I/R. Differential pyroptosis-related genes were identified from transcriptomics data and validated with proteomics. Single-cell RNA sequencing assessed pyroptosis levels and intercellular communication. Mouse myocardial I/R and human cardiomyocyte hypoxia/reoxygenation (H/R) models were used to explore STING overexpression/silencing effects on NLRP3 inflammasome activation, oxidative stress, and cellular injury. Results: Pyroptosis-related genes were significantly dysregulated, implicating multiple inflammatory pathways. Single-cell analyses revealed increased granulocytes, macrophage infiltration, cardiomyocyte injury, and enhanced pyroptosis scores post-I/R. Cardiomyocytes, endothelial cells, and fibroblasts exhibited increased pyroptosis and inflammatory cell-cell interactions. Animal studies indicated significant declines in cardiac function and increased oxidative stress and inflammation post-I/R. STING activation (SR717) worsened cardiac function, enhanced ROS production, and elevated myocardial injury markers; STING inhibition (H151) markedly mitigated these effects. Correspondingly, the cGAS-STING pathway and NLRP3 inflammasome factors were significantly upregulated post-I/R, exacerbated by STING agonists and alleviated by STING inhibitors. Cellular studies confirmed that STING overexpression intensified oxidative stress and pyroptosis, effects reversed by STING knockdown and blocked by NLRP3 inhibitor MCC950. Conclusion: STING activation contributes to oxidative stress and NLRP3 inflammasome–associated pyroptosis during I/R. Targeting the STING-NLRP3 axis may represent a potential strategy to reduce myocardial injury after ischemia-reperfusion.

19 December 2024 in Health Science Reports
Verified
Journal Article
Open access
RYRui Yan
Rui Yan
HZHui Zhang
Hui Zhang
BSBo Shi
Bo Shi
CYCongyan Ye
Congyan Ye
SFShizhe Fu
Shizhe Fu
GCGuangzhi Cong
Guangzhi Cong
Background and Aims: The role of sex disparities in in‐hospital outcomes after percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in patients with a history of coronary artery bypass grafting (CABG) remains underexplored. This study aimed to identify sex disparities in in‐hospital outcomes after PCI in patients with AMI and a history of CABG.Methods: Using the National Inpatient Sample database, we identified patients hospitalized for AMI with a history of CABG who underwent PCI between 2016 and 2019. 1:1 propensity score matching was used to minimize standardized mean differences of baseline variables and compare in‐­hospital outcomes.Results: In total, 75,185 weighted hospitalizations of patients were identified. Compared with male patients, female patients exhibited elevated risks of in‐hospital mortality (3.72% vs. 2.85%; adjusted odds ratio [aOR] 1.48; 95% confidence interval [CI] 1.14–1.93), major adverse cardiac or cerebrovascular events (MACCEs) (4.96% vs. 3.75%; aOR 1.46; 95% CI 1.18–1.82), bleeding (4.91% vs. 3.01%; aOR 1.56; 95% CI 1.27–1.79), and longer length of stay (4.64 days vs. 3.96 days; β 0.42; 95% CI 0.28–0.55). After propensity matching, female patients remained associated with increased risks of in‐hospital mortality (3.81% vs. 2.81%; aOR 1.37; 95% CI 1.06–1.78), MACCEs (5.08% vs. 3.84%; aOR 1.35; 95% CI 1.08–1.70), bleeding (5.03% vs. 3.11%; aOR 1.57; 95% CI 1.24–2.00), and longer length of stay (4.61 ± 4.76 days vs. 4.06 ± 4.10 days; β 0.39; 95% CI 0.18–0.59). Female patients aged > 60 years were more vulnerable to in‐hospital mortality than were their male counterparts (3.06% vs. 4.15%; aOR 1.56; 95% CI 1.18–2.05).Conclusions: Female patients who underwent PCI for AMI with a history of CABG had higher risks of in‐hospital mortality, MACCEs, bleeding, and longer length of stay, with in‐hospital mortality rates being particularly pronounced among older patients.

28 September 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
QZQinning Zhang
Qinning Zhang
LYLibo Yang
Libo Yang
MCMeng Cao
Meng Cao
RYRu Yan
Ru Yan
BZBaozhen Zhu
Baozhen Zhu
SJShaobin Jia
Shaobin Jia
Background: Stent malapposition (SM) remains a significant challenge in percutaneous coronary intervention (PCI), particularly in cases involving calcified coronary lesions. However, the predictors of SM and their relationship with clinical outcomes remains unclear. This study aims to identify the predictors of SM through optical coherence tomography (OCT) and assess its impact on clinical outcomes. Methods: In this single-center, retrospective observational study, we analyzed 384 patients who underwent PCI with OCT imaging for calcified coronary lesions between January 2019 and December 2023. Patients were divided into two groups based on post-PCI OCT findings: the SM group (n = 142) and non-SM group (n = 242). We compared calcium characteristics, procedural parameters, and clinical outcomes between the two groups. Results: The SM group exhibited more severe calcium characteristics, including a larger calcium arc (295.8° ± 58.4° vs 248.6° ± 62.3°, p < 0.001), greater thickness (1.12 ± 0.31 mm vs 0.89 ± 0.28 mm, p < 0.001), and longer length (18.6 ± 7.2 mm vs 12.8 ± 6.4 mm, p < 0.001). Multivariate analysis identified calcium arc >270° (odds ratio (OR) 2.84, 95% CI 1.86–4.32, p < 0.001), calcium thickness >1.0 mm (OR 2.16, 95% CI 1.42–3.28, p = 0.001), and diabetes mellitus (OR 1.68, 95% CI 1.12–2.52, p = 0.012) as independent predictors of SM. Over a median follow-up of 18.6 months, the SM group had higher rates of major adverse cardiovascular events (15.5% vs 8.7%, p = 0.04), primarily driven by increased target lesion revascularization (8.5% vs 4.1%, p = 0.03). Conclusions: Specific calcium characteristics and diabetes mellitus are strong predictors of stent malapposition in calcified coronary lesions. The presence of stent malapposition is associated with worse clinical outcomes, highlighting the importance of optimal lesion preparation and stent deployment strategies in high-risk lesions.

17 May 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
RYRui Yan
Rui Yan
JYJie Yang
Jie Yang
BSBo Shi
Bo Shi
CYCongyan Ye
Congyan Ye
SFShizhe Fu
Shizhe Fu
GCGuangzhi Cong
Guangzhi Cong
Mechanical circulatory support (MCS) devices have been widely used for managing acute myocardial infarction complicated by cardiogenic shock (AMI-CS). However, their use additionally elevates acute ischemic stroke (AIS) risk. There is insufficient data on the risk of AIS associated with early versus late initiation of MCS in AMI-CS cases. Therefore, this study aimed to assess the timing of MCS initiation associated with the risk of AIS in hospitalizations with AMI-CS. A retrospective data analysis of the National Inpatient Sample (January 2016–December 2020) identified AMI-CS hospitalizations: categorized into early MCS initiation (< 48 h) and late MCS initiation (> 48 h). The primary outcome was AIS; the secondary outcomes included in-hospital mortality, acute kidney injury (AKI), cardiac arrest, major bleeding, and blood transfusion. The outcomes were compared using logistic multivariate regression and 1:1 propensity score matching analyses between the groups. Among 78,405 weighted hospitalizations with AMI-CS receiving MCS, 82.77% (n = 64,895) and 17.23% (n = 13,510) underwent early and late MCS initiation, respectively. Hospitalizations with late MCS initiation had higher risks of AIS (adjusted odds ratio [aOR], 1.46; 95%confidence interval [CI], 1.19–1.79; p < 0.001), AKI (aOR, 1.41; 95%CI, 1.27–1.55; p < 0.001), and major bleeding (aOR, 1.12; 95%CI, 1.01–1.23; p = 0.028). After propensity score matching, late MCS initiation remained associated with increased risks of AIS (aOR, 1.39; 95%CI, 1.08–1.78; p = 0.010), AKI (aOR, 1.37; 95%CI, 1.23–1.53; p < 0.001), and major bleeding (aOR, 1.14; 95%CI, 1.02–1.28; p = 0.027). Late initiation of MCS was associated with increased risks of AIS, AKI, and major bleeding.